Physician profile
Sevan V Stepanian
NPI 1790941029
$4,573.10
in general payments reported to CMS, 2019-2025
19 companies · $33.20 in 2025
The $33.20 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $1,596 · 2021: $191 · 2022: $1,233 · 2023: $81.00 · 2024: $1,083 · 2025: $33.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,197.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Richard Wolf Medical Instruments Corp. | $1,500.00 | 2020 | |
| Teleflex LLC | $1,350.48 | 2021-2025 | Urolift, Barrigel |
| Edap Technomed INC | $744.00 | 2024 | |
| Olympus America INC. | $160.61 | 2021-2022 | |
| Medtronic USA, INC. | $143.32 | 2019 | |
| Neotract INC. | $142.00 | 2019 | |
| Boston Scientific Corporation | $79.05 | 2019-2024 | Rezum Generator |
| Intuitive Surgical, INC. | $74.00 | 2021-2024 | |
| Dornier Medtech America, INC | $72.52 | 2020 | |
| Procept Biorobotics Corporation | $62.76 | 2022-2023 | Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $45.07 | 2022 | |
| Bluewind Medical | $43.78 | 2024 | Revi |
| Myriad Genetic Laboratories, INC. | $36.37 | 2023 | Prolaris |
| Calyxo, INC. | $32.23 | 2024 | Cvac Aspiration System |
| Tolmar Pharmaceuticals, INC. | $24.76 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $19.05 | 2019 | |
| Coloplast Corp | $16.39 | 2022 | |
| Dexcom, INC. | $13.38 | 2021 | |
| Sumitomo Pharma America, INC. | $13.33 | 2024 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sevan Stepanian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.